Suchen
AC Immune SA
ACIUZur Watchlist hinzufügen
2.660USD
-0.170-6.01%
Handelsschluss 09-24 16:00（ET）
270.71MMarktkapitalisierung
VerlustKGV TTM
Über AC Immune SA Unternehmen
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
AC Immune SA Profil
BörsenkürzelACIU
Name des UnternehmensAC Immune SA
IPO-datumSep 23, 2016
CEOPfeifer (Andrea)
Anzahl der mitarbeiter133
WertpapierartOrdinary Share
GeschäftsjahresendeSep 23
AddresseEPFL Innovation Park
StadtLAUSANNE
BörseNASDAQ OMX - NASDAQ BASIC
LandSwitzerland
Postleitzahl1015
Telefon41213459121
Websitehttps://www.acimmune.com/
BörsenkürzelACIU
IPO-datumSep 23, 2016
CEOPfeifer (Andrea)
Führungskräfte von AC Immune SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Mr. Piergiorgio Donati
Mr. Piergiorgio Donati
Chief Technical Operations Officer
Chief Technical Operations Officer
74.24K
+38.31%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von AC Immune SA?
Die fünf größten Anteilseigner von AC Immune SA sind: Prof. Dr. Andrea Pfeifer, Ph.D.
Wie viele Institutionen halten Anteile an AC Immune SA (ACIU)?
Mit Stand vom 2026Q1 halten 106 Institutionen Anteile an AC Immune SA, mit einem Gesamtmarktwert von etwa 26.78M, was 26.32% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1698579.00 gestiegen.